glp-1 hub for Weight Loss and Diabetes Introducing the GLP-1 Hub Membership

Physical Activity is strongly associated with sustained weight loss maintenance

GLP-1 Drugs Approved in the United States Below is the current list of major FDA-approved GLP-1 drugs in the United States, organized by active ingredient

Rondanelli M, Perna S, Riva A, Petrangolini G, Di Paolo E, Gasparri C

GOAL: To give the pharmacist a clinical and pharmacotherapeutic overview of dipeptidyl peptidase-4 (DPP-4) inhibitors available in the United States for treatment of type 2 diabetes

A phase 2, adaptive randomized, double-blind, placebo-controlled, multicenter, 52-week study of HM15211 in patients with biopsy-confirmed non-alcoholic steatohepatitis - Study design and rationale of HM-TRIA-201 study

If youre experiencing ongoing fatigue, decreased appetite, or any side effects, our team is here to listen and help